ConductScience.org, home

Paper324783

Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen.

Beaudoin RL and 3 others. Exp Parasitol, 1977. Cited by 86 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Papers, record 324783. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/324783

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen.
PubMed
Journal
Exp Parasitol
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
86
iCite
Relative citation ratio, by iCite
1.58
iCite
Revised in PubMed
2019-08-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Beaudoin RLR L
2Strome CPC P
3Mitchell FF
4Tubergen TAT A

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntigensMajor topic
ImmunizationMajor topic
MalariaMajor topic
Plasmodium bergheiMajor topic
Animals
Immunity
Mice

Source PubMed

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.

PMIDTitleJournalYearIn PapersSource
41,023,197Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanil.EMBO Mol Med2025https://conductscience.org/library/papers/41023197PubMed
40,424,562Long lived liver-resident memory T cells of biased specificities for abundant sporozoite antigens drive malaria protection by radiation-attenuated sporozoite vaccination.PLoS Pathog2025https://conductscience.org/library/papers/40424562PubMed
37,680,630Induction of liver-resident memory T cells and protection at liver-stage malaria by mRNA-containing lipid nanoparticles.Front Immunol2023https://conductscience.org/library/papers/37680630PubMed
37,571,809Sporozoite immunization: innovative translational science to support the fight against malaria.Expert Rev Vaccines2023https://conductscience.org/library/papers/37571809PubMed
36,593,995Antibody-dependent immune responses elicited by blood stage-malaria infection contribute to protective immunity to the pre-erythrocytic stages.Curr Res Immunol2023https://conductscience.org/library/papers/36593995PubMed
36,159,849Five decades of clinical assessment of whole-sporozoite malaria vaccines.Front Immunol2022https://conductscience.org/library/papers/36159849PubMed
35,641,527Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens.NPJ Vaccines2022https://conductscience.org/library/papers/35641527PubMed
35,357,277Current status of experimental models for the study of malaria.Parasitology2022https://conductscience.org/library/papers/35357277PubMed
34,135,099Dissection-independent production of Plasmodium sporozoites from whole mosquitoes.Life Sci Alliance2021https://conductscience.org/library/papers/34135099PubMed
34,031,479Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice.Sci Rep2021https://conductscience.org/library/papers/34031479PubMed
31,231,377Vaccination With Sporozoites: Models and Correlates of Protection.Front Immunol2019https://conductscience.org/library/papers/31231377PubMed
30,510,775Pre-clinical evaluation of a P. berghei-based whole-sporozoite malaria vaccine candidate.NPJ Vaccines2018https://conductscience.org/library/papers/30510775PubMed
30,323,025Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.Infect Immun2019https://conductscience.org/library/papers/30323025PubMed
30,155,278A Plasmodium berghei sporozoite-based vaccination platform against human malaria.NPJ Vaccines2018https://conductscience.org/library/papers/30155278PubMed
29,892,289Varying Immunizations With Plasmodium Radiation-Attenuated Sporozoites Alter Tissue-Specific CD8+ T Cell Dynamics.Front Immunol2018https://conductscience.org/library/papers/29892289PubMed
28,438,976Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.Infect Immun2017https://conductscience.org/library/papers/28438976PubMed
28,199,305Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.Nature2017https://conductscience.org/library/papers/28199305PubMed
28,077,589Trimethoprim-Sulfamethoxazole Prophylaxis During Live Malaria Sporozoite Immunization Induces Long-Lived, Homologous, and Heterologous Protective Immunity Against Sporozoite Challenge.J Infect Dis2017https://conductscience.org/library/papers/28077589PubMed
27,867,517Protective immunity to liver-stage malaria.Clin Transl Immunology2016https://conductscience.org/library/papers/27867517PubMed
27,855,488An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials.Future Microbiol2016https://conductscience.org/library/papers/27855488PubMed

See all 46 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/324783

GET https://conductscience.org/api/papers/v1/324783/cited_by?page=2